Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Caculitan NG"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Liang J; Department of Chemistry, University of Akron, Akron, OH 44325., Seghiri M; Department of Chemistry, University of Akron, Akron, OH 44325.; Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409., Singh PK; Department of Chemistry, University of Akron, Akron, OH 44325.; Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409., Seo HG; GPCR Therapeutics Inc., Gwanak-gu, Seoul 08790, Republic of Korea., Lee JY; GPCR Therapeutics Inc., Gwanak-gu, Seoul 08790, Republic of Korea., Jo Y; GPCR Therapeutics Inc., Gwanak-gu, Seoul 08790, Republic of Korea., Song YB; School of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea., Park C; School of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea., Zalicki P; GPCR Therapeutics Inc., Gwanak-gu, Seoul 08790, Republic of Korea., Jeong JY; GPCR Therapeutics Inc., Gwanak-gu, Seoul 08790, Republic of Korea., Huh WK; School of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea.; Institute of Microbiology, Seoul National University, Seoul 08826, Republic of Korea., Caculitan NG; GPCR Therapeutics Inc., Gwanak-gu, Seoul 08790, Republic of Korea., Smith AW; Department of Chemistry, University of Akron, Akron, OH 44325.; Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Apr 02; Vol. 121 (14), pp. e2304897121. Date of Electronic Publication: 2024 Mar 28.
Autor:
Sukhtankar DD; GPCR Therapeutics, Inc., Seoul, South Korea.; GPCR Therapeutics USA, Redwood City, CA, USA., Chang LW; TaiGen Biotechnology Col Ltd, Taipei, Taiwan., Tsai CY; TaiGen Biotechnology Col Ltd, Taipei, Taiwan., Cardarelli PM; GPCR Therapeutics, Inc., Seoul, South Korea.; GPCR Therapeutics USA, Redwood City, CA, USA., Caculitan NG; GPCR Therapeutics, Inc., Seoul, South Korea.; GPCR Therapeutics USA, Redwood City, CA, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Nov; Vol. 12 (11), pp. 1114-1120. Date of Electronic Publication: 2023 Aug 04.
Autor:
Sukhtankar DD; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America., Fung JJ; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America., Kim MN; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Cayton T; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America., Chiou V; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America., Caculitan NG; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America., Zalicki P; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America., Kim S; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Jo Y; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Kim S; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Lee JM; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Choi J; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Mun S; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Chin A; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America., Jang Y; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Lee JY; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Kim G; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Kim EH; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Huh WK; School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.; Institute of Microbiology, Seoul National University, Seoul, Republic of Korea., Jeong JY; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Seen DS; GPCR Therapeutics Inc., Gwanak-gu, Seoul, Republic of Korea., Cardarelli PM; GPCR Therapeutics USA, Inc., Redwood City, California, United States of America.
Publikováno v:
PloS one [PLoS One] 2023 Oct 25; Vol. 18 (10), pp. e0287863. Date of Electronic Publication: 2023 Oct 25 (Print Publication: 2023).
Autor:
Caculitan NG; Genentech, Inc., South San Francisco, California., Dela Cruz Chuh J; Genentech, Inc., South San Francisco, California., Ma Y; Genentech, Inc., South San Francisco, California., Zhang D; Genentech, Inc., South San Francisco, California., Kozak KR; Genentech, Inc., South San Francisco, California., Liu Y; Genentech, Inc., South San Francisco, California., Pillow TH; Genentech, Inc., South San Francisco, California., Sadowsky J; Genentech, Inc., South San Francisco, California., Cheung TK; Genentech, Inc., South San Francisco, California., Phung Q; Genentech, Inc., South San Francisco, California., Haley B; Genentech, Inc., South San Francisco, California., Lee BC; 23andMe, South San Francisco, California., Akita RW; Genentech, Inc., South San Francisco, California., Sliwkowski MX; Genentech, Inc., South San Francisco, California., Polson AG; Genentech, Inc., South San Francisco, California. polson@gene.com.
Publikováno v:
Cancer research [Cancer Res] 2017 Dec 15; Vol. 77 (24), pp. 7027-7037. Date of Electronic Publication: 2017 Oct 18.
Autor:
Caculitan NG; Howard Hughes Medical Institute, Department of Chemistry, University of California , Berkeley, California 94720, United States., Kai H, Liu EY, Fay N, Yu Y, Lohmüller T, O'Donoghue GP, Groves JT
Publikováno v:
Nano letters [Nano Lett] 2014 May 14; Vol. 14 (5), pp. 2293-8. Date of Electronic Publication: 2014 Apr 02.